Global Somatostatin Market Analysis and Forecast 2024-2030

Global Somatostatin Market Analysis and Forecast 2024-2030


Summary

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

According to APO Research, The global Somatostatin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Somatostatin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Somatostatin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Somatostatin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Somatostatin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Somatostatin include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO and TianTaiShan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Somatostatin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Somatostatin, also provides the sales of main regions and countries. Of the upcoming market potential for Somatostatin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Somatostatin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Somatostatin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Somatostatin sales, projected growth trends, production technology, application and end-user industry.

Somatostatin segment by Company

Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Somatostatin segment by Type
0.25mg/pcs0.75mg/pcs
3mg/pcs
Somatostatin segment by Application

Hormonal Disorder
Oncology
Metabolic Disorder
Others
Somatostatin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Somatostatin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Somatostatin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Somatostatin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Somatostatin Market by Type
1.2.1 Global Somatostatin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 0.25mg/pcs
1.2.3 0.75mg/pcs
1.2.4 3mg/pcs
1.3 Somatostatin Market by Application
1.3.1 Global Somatostatin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Somatostatin Market Dynamics
2.1 Somatostatin Industry Trends
2.2 Somatostatin Industry Drivers
2.3 Somatostatin Industry Opportunities and Challenges
2.4 Somatostatin Industry Restraints
3 Global Market Growth Prospects
3.1 Global Somatostatin Revenue Estimates and Forecasts (2019-2030)
3.2 Global Somatostatin Revenue by Region
3.2.1 Global Somatostatin Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Somatostatin Revenue by Region (2019-2024)
3.2.3 Global Somatostatin Revenue by Region (2025-2030)
3.2.4 Global Somatostatin Revenue Market Share by Region (2019-2030)
3.3 Global Somatostatin Sales Estimates and Forecasts 2019-2030
3.4 Global Somatostatin Sales by Region
3.4.1 Global Somatostatin Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Somatostatin Sales by Region (2019-2024)
3.4.3 Global Somatostatin Sales by Region (2025-2030)
3.4.4 Global Somatostatin Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Somatostatin Revenue by Manufacturers
4.1.1 Global Somatostatin Revenue by Manufacturers (2019-2024)
4.1.2 Global Somatostatin Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Somatostatin Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Somatostatin Sales by Manufacturers
4.2.1 Global Somatostatin Sales by Manufacturers (2019-2024)
4.2.2 Global Somatostatin Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Somatostatin Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Somatostatin Sales Price by Manufacturers (2019-2024)
4.4 Global Somatostatin Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Somatostatin Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Somatostatin Manufacturers, Product Type & Application
4.7 Global Somatostatin Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Somatostatin Market CR5 and HHI
4.8.2 2023 Somatostatin Tier 1, Tier 2, and Tier 3
5 Somatostatin Market by Type
5.1 Global Somatostatin Revenue by Type
5.1.1 Global Somatostatin Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Somatostatin Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Somatostatin Revenue Market Share by Type (2019-2030)
5.2 Global Somatostatin Sales by Type
5.2.1 Global Somatostatin Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Somatostatin Sales by Type (2019-2030) & (K Pcs)
5.2.3 Global Somatostatin Sales Market Share by Type (2019-2030)
5.3 Global Somatostatin Price by Type
6 Somatostatin Market by Application
6.1 Global Somatostatin Revenue by Application
6.1.1 Global Somatostatin Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Somatostatin Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Somatostatin Revenue Market Share by Application (2019-2030)
6.2 Global Somatostatin Sales by Application
6.2.1 Global Somatostatin Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Somatostatin Sales by Application (2019-2030) & (K Pcs)
6.2.3 Global Somatostatin Sales Market Share by Application (2019-2030)
6.3 Global Somatostatin Price by Application
7 Company Profiles
7.1 Merck (Schweiz) AG
7.1.1 Merck (Schweiz) AG Comapny Information
7.1.2 Merck (Schweiz) AG Business Overview
7.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck (Schweiz) AG Somatostatin Product Portfolio
7.1.5 Merck (Schweiz) AG Recent Developments
7.2 SANOFI-AVENTIS FRANCE
7.2.1 SANOFI-AVENTIS FRANCE Comapny Information
7.2.2 SANOFI-AVENTIS FRANCE Business Overview
7.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio
7.2.5 SANOFI-AVENTIS FRANCE Recent Developments
7.3 Lyomark Pharma GmbH
7.3.1 Lyomark Pharma GmbH Comapny Information
7.3.2 Lyomark Pharma GmbH Business Overview
7.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Lyomark Pharma GmbH Somatostatin Product Portfolio
7.3.5 Lyomark Pharma GmbH Recent Developments
7.4 ALFA WASSERMANN S.p.A.
7.4.1 ALFA WASSERMANN S.p.A. Comapny Information
7.4.2 ALFA WASSERMANN S.p.A. Business Overview
7.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio
7.4.5 ALFA WASSERMANN S.p.A. Recent Developments
7.5 Polypeptide Laboratories, Inc
7.5.1 Polypeptide Laboratories, Inc Comapny Information
7.5.2 Polypeptide Laboratories, Inc Business Overview
7.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Polypeptide Laboratories, Inc Somatostatin Product Portfolio
7.5.5 Polypeptide Laboratories, Inc Recent Developments
7.6 SAMARTH
7.6.1 SAMARTH Comapny Information
7.6.2 SAMARTH Business Overview
7.6.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 SAMARTH Somatostatin Product Portfolio
7.6.5 SAMARTH Recent Developments
7.7 UBPL
7.7.1 UBPL Comapny Information
7.7.2 UBPL Business Overview
7.7.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 UBPL Somatostatin Product Portfolio
7.7.5 UBPL Recent Developments
7.8 HYBIO
7.8.1 HYBIO Comapny Information
7.8.2 HYBIO Business Overview
7.8.3 HYBIO Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 HYBIO Somatostatin Product Portfolio
7.8.5 HYBIO Recent Developments
7.9 TianTaiShan
7.9.1 TianTaiShan Comapny Information
7.9.2 TianTaiShan Business Overview
7.9.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 TianTaiShan Somatostatin Product Portfolio
7.9.5 TianTaiShan Recent Developments
7.10 Yangtze River
7.10.1 Yangtze River Comapny Information
7.10.2 Yangtze River Business Overview
7.10.3 Yangtze River Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Yangtze River Somatostatin Product Portfolio
7.10.5 Yangtze River Recent Developments
7.11 Siyao
7.11.1 Siyao Comapny Information
7.11.2 Siyao Business Overview
7.11.3 Siyao Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Siyao Somatostatin Product Portfolio
7.11.5 Siyao Recent Developments
7.12 Shuangcheng
7.12.1 Shuangcheng Comapny Information
7.12.2 Shuangcheng Business Overview
7.12.3 Shuangcheng Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Shuangcheng Somatostatin Product Portfolio
7.12.5 Shuangcheng Recent Developments
7.13 Hainan Zhonghe
7.13.1 Hainan Zhonghe Comapny Information
7.13.2 Hainan Zhonghe Business Overview
7.13.3 Hainan Zhonghe Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Hainan Zhonghe Somatostatin Product Portfolio
7.13.5 Hainan Zhonghe Recent Developments
7.14 SL PHARM
7.14.1 SL PHARM Comapny Information
7.14.2 SL PHARM Business Overview
7.14.3 SL PHARM Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 SL PHARM Somatostatin Product Portfolio
7.14.5 SL PHARM Recent Developments
7.15 Wuhan Hualong
7.15.1 Wuhan Hualong Comapny Information
7.15.2 Wuhan Hualong Business Overview
7.15.3 Wuhan Hualong Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Wuhan Hualong Somatostatin Product Portfolio
7.15.5 Wuhan Hualong Recent Developments
7.16 Qingdao Guoda
7.16.1 Qingdao Guoda Comapny Information
7.16.2 Qingdao Guoda Business Overview
7.16.3 Qingdao Guoda Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Qingdao Guoda Somatostatin Product Portfolio
7.16.5 Qingdao Guoda Recent Developments
7.17 Chengdu Shengnuo
7.17.1 Chengdu Shengnuo Comapny Information
7.17.2 Chengdu Shengnuo Business Overview
7.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Chengdu Shengnuo Somatostatin Product Portfolio
7.17.5 Chengdu Shengnuo Recent Developments
7.18 Longjin
7.18.1 Longjin Comapny Information
7.18.2 Longjin Business Overview
7.18.3 Longjin Somatostatin Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Longjin Somatostatin Product Portfolio
7.18.5 Longjin Recent Developments
8 North America
8.1 North America Somatostatin Market Size by Type
8.1.1 North America Somatostatin Revenue by Type (2019-2030)
8.1.2 North America Somatostatin Sales by Type (2019-2030)
8.1.3 North America Somatostatin Price by Type (2019-2030)
8.2 North America Somatostatin Market Size by Application
8.2.1 North America Somatostatin Revenue by Application (2019-2030)
8.2.2 North America Somatostatin Sales by Application (2019-2030)
8.2.3 North America Somatostatin Price by Application (2019-2030)
8.3 North America Somatostatin Market Size by Country
8.3.1 North America Somatostatin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Somatostatin Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Somatostatin Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Somatostatin Market Size by Type
9.1.1 Europe Somatostatin Revenue by Type (2019-2030)
9.1.2 Europe Somatostatin Sales by Type (2019-2030)
9.1.3 Europe Somatostatin Price by Type (2019-2030)
9.2 Europe Somatostatin Market Size by Application
9.2.1 Europe Somatostatin Revenue by Application (2019-2030)
9.2.2 Europe Somatostatin Sales by Application (2019-2030)
9.2.3 Europe Somatostatin Price by Application (2019-2030)
9.3 Europe Somatostatin Market Size by Country
9.3.1 Europe Somatostatin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Somatostatin Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Somatostatin Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Somatostatin Market Size by Type
10.1.1 China Somatostatin Revenue by Type (2019-2030)
10.1.2 China Somatostatin Sales by Type (2019-2030)
10.1.3 China Somatostatin Price by Type (2019-2030)
10.2 China Somatostatin Market Size by Application
10.2.1 China Somatostatin Revenue by Application (2019-2030)
10.2.2 China Somatostatin Sales by Application (2019-2030)
10.2.3 China Somatostatin Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Somatostatin Market Size by Type
11.1.1 Asia Somatostatin Revenue by Type (2019-2030)
11.1.2 Asia Somatostatin Sales by Type (2019-2030)
11.1.3 Asia Somatostatin Price by Type (2019-2030)
11.2 Asia Somatostatin Market Size by Application
11.2.1 Asia Somatostatin Revenue by Application (2019-2030)
11.2.2 Asia Somatostatin Sales by Application (2019-2030)
11.2.3 Asia Somatostatin Price by Application (2019-2030)
11.3 Asia Somatostatin Market Size by Country
11.3.1 Asia Somatostatin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Somatostatin Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Somatostatin Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Somatostatin Market Size by Type
12.1.1 MEALA Somatostatin Revenue by Type (2019-2030)
12.1.2 MEALA Somatostatin Sales by Type (2019-2030)
12.1.3 MEALA Somatostatin Price by Type (2019-2030)
12.2 MEALA Somatostatin Market Size by Application
12.2.1 MEALA Somatostatin Revenue by Application (2019-2030)
12.2.2 MEALA Somatostatin Sales by Application (2019-2030)
12.2.3 MEALA Somatostatin Price by Application (2019-2030)
12.3 MEALA Somatostatin Market Size by Country
12.3.1 MEALA Somatostatin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Somatostatin Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Somatostatin Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Somatostatin Value Chain Analysis
13.1.1 Somatostatin Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Somatostatin Production Mode & Process
13.2 Somatostatin Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Somatostatin Distributors
13.2.3 Somatostatin Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings